OptiNose, Inc.’s top owners (NASDAQ:OPTN), are private equity firms, with 37% stake, and 33% by institutions

You can see who really controls OptiNose Inc.NASDAQ:OPTNUnderstanding the ownership structure is critical. Private equity firms hold 37% of the shares, making them the largest shareholders. This means that the group can either gain or lose the most from their investment in the company.

Meanwhile, institutions make up 33% of the company’s shareholders. Intenders own large portions of smaller, younger companies, while institutions are more common in larger companies.

Let’s have a closer look at what different shareholders have to say about OptiNose.

Check out our latest analysis for OptiNose

ownership-breakdown

ownership-breakdown

What Does the Institutional Ownership Say About OptiNose

Institutional investors often compare their returns to those of an index. They will often consider purchasing larger companies that are part of the benchmark index.

We can see that OptiNose is backed by institutional investors. This shows that professional investors have some trust in OptiNose. However, we cannot rely solely on this fact. Institutions can make poor investments at times just as everyone else. There is always the possibility that multiple institutions may own a stock. Multiple parties could try to sell stock quickly if a trade goes wrong. If a company has not had a long history of growth, this risk is greater. You can see OptiNose’s revenue and earnings history below. However, there are always more details.

earnings-and-revenue-growth

earnings-and-revenue-growth

Hedge funds are not allowed to make meaningful investments in OptiNose. Avista Capital holdings, L.P., with 13% shares outstanding, is the largest shareholder. MVM Partners LLP & FMR LLC are second and third, respectively, with equal shares at 11%. Peter Miller, the CEO of MVM Partners LLP, also holds 0.6%.

We did more research and discovered that 6 of top shareholders account roughly for 52% of register. This implies that there are smaller shareholders as well as larger shareholders. Thus, each shareholder is somewhat balanced.

Although institutional ownership can be a valuable addition to your research, it’s also a good idea to study analyst recommendations to gain a better understanding of the stock’s future performance. It might be worthwhile to get a comprehensive view from all analysts who cover the stock.

Insider Ownership of OptiNose

Definitions of company insiders are subjective and can differ from jurisdiction to jurisdiction. Our data includes individual insiders and board members. The board should be able to see the answers of company management and the latter should represent shareholders’ interests. Sometimes, top-ranking managers serve on the board.

When leadership thinks like true owners of the company, insider ownership can be a positive sign. But, insider ownership may also give immense power and influence to a small number of people. This can be a problem in certain situations.

Our latest data shows that some shares are owned by insiders at OptiNose. Insiders hold stock worth US$9.0m, which is US$186m. Although it’s good to see investment from insiders, we would prefer higher insider holdings. This might be worth looking into. if those insiders have been buying.

General Public Ownership

The public, mostly made up of individuals investors, has a 25% ownership. This gives them some influence over OptiNose. Even though this ownership is substantial, it may not be sufficient to alter company policy if the decision does not reflect the views of other large shareholders.

Private Equity Ownership

A 37% stake could allow private equity firms to influence the OptiNose Board. This might be a good thing for some, as private equity firms can sometimes act as activists and hold management accountable. Private equity can also sell out and take the company public.

Next steps:

It is worth considering the various ownership groups of shares in a company. We must consider other factors to make OptiNose more understandable. We’ve also discovered 4 warning signs for OptiNose (1 is a little unpleasant!) Before you invest here, there are some things that you should know.

Let us hope that this helps. The future is the most important. This information is available to you No cost report on analyst forecasts for the company.

NB. The figures in this article are based on data from the past twelve months. These refer to the 12-month period ending with the date of the last financial statement. This could not be consistent with full-year annual report figures.

Give feedback about this article Are you concerned about the content? Get in touch Contact us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article is general in nature by Simply Wall St. We only provide commentary on historical data and analyst projections. Our articles are not meant to be considered financial advice. It is not a recommendation not to buy or sell any stocks and it doesn’t take into account your objectives or financial situation. We strive to deliver long-term focused analysis that is based on fundamental data. Our analysis may not take into account the most recent price-sensitive company announcements and qualitative material. Simply Wall St does not hold any position in the stocks mentioned.

Participate in a Paid User Research Session
You’ll receive a Amazon Gift Card – US$30 Spend an hour helping us to create better tools for individual investors. Sign up here

Previous post Brenton Strange declares for NFL draft
Next post Clippers win over Raptors with Powell and Leonard